Publications by authors named "Mercedeh Mansourian"

Claim this Profile
C
Compatibility of Active Pharmaceutical Ingredients in Cleoderm™: A Comprehensive Study for Enhanced Topical Dermatological Treatments.
Bruna Marianni, Mercedeh Mansourian, Savvas Koulouridas, Hudson Polonini

Int J Pharm Compd· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Compatibility of Commonly Used Active Pharmaceutical Ingredients in a Ready-to-Use Oral Suspending Vehicle.
Mercedeh Mansourian, Eli Dijkers, Carolina C V Silva, Hudson C Polonini

Pharmaceutics· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased Targeting Area in Tumors by Dual-Ligand Modification of Liposomes with RGD and TAT Peptides.
Mohamadreza Amin, Mercedeh Mansourian, Peter C Burgers, Bahareh Amin, Mahmoud Reza Jaafari

Pharmaceutics· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preparation of nanoliposomes containing HER2/neu (P5+435) peptide and evaluation of their immune responses and anti-tumoral effects as a prophylactic vaccine against breast cancer.
Laleh Naghibi, Mona Yazdani, Amir Abbas Momtazi-Borojeni, Atefeh Razazan, Sheida Shariat, Mercedeh Mansourian

PLoS One· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
P435 HER2/neu-derived peptide conjugated to liposomes containing DOPE as an effective prophylactic vaccine formulation for breast cancer.
Niloofar Farzad, Nastaran Barati, Amir Abbas Momtazi-Borojeni, Mona Yazdani, Atefeh Arab, Mercedeh Mansourian

Artif Cells Nanomed Biotechnol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preparation of nanoliposomes linked to HER2/neu-derived (P5) peptide containing MPL adjuvant as vaccine against breast cancer.
Saeedeh Rastakhiz, Mona Yazdani, Sheida Shariat, Atefeh Arab, Amir Abbas Momtazi-Borojeni, Mercedeh Mansourian

J Cell Biochem· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of in vivo behavior of TAT-modified liposome by associated protein corona and avidity to tumor cells.
Mohamadreza Amin, Mahsa Bagheri, Mercedeh Mansourian, Mahmoud Reza Jaafari, Timo Lm Ten Hagen

Int J Nanomedicine· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stimulation of Tumor-Specific Immunity by p5 HER-2/neu Generated Peptide Encapsulated in Nano-liposomes with High Phase Transition Temperature Phospholipids.
Mona Yazdani, Seyed Amir Jalali, Ali Badiee, Sheida Shariat, Mercedeh Mansourian

Curr Drug Deliv· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Self-Assembling Peptide Epitopes as Novel Platform for Anticancer Vaccination.
Mazda Rad-Malekshahi, Marieke F Fransen, Małgorzata Krawczyk, Mercedeh Mansourian, Meriem Bourajjaj

Mol Pharm· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poly (I:C)-DOTAP cationic nanoliposome containing multi-epitope HER2-derived peptide promotes vaccine-elicited anti-tumor immunity in a murine model.
Ghazal Alipour Talesh, Zahra Ebrahimi, Ali Badiee, Mercedeh Mansourian, Hossein Attar

Immunol Lett· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a novel cyclic RGD peptide for multiple targeting approaches of liposomes to tumor region.
Mohamadreza Amin, Mercedeh Mansourian, Gerben A Koning, Ali Badiee, Mahmoud Reza Jaafari

J Control Release· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preparation and characterization of different liposomal formulations containing P5 HER2/neu-derived peptide and evaluation of their immunological responses and antitumor effects.
Sheida Shariat, Ali Badiee, Seyed Amir Jalali, Mercedeh Mansourian, Seyed Alireza Mortazavi

Iran J Basic Med Sci· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
P5 HER2/neu-derived peptide conjugated to liposomes containing MPL adjuvant as an effective prophylactic vaccine formulation for breast cancer.
Sheida Shariat, Ali Badiee, Seyed Amir Jalali, Mercedeh Mansourian, Mona Yazdani

Cancer Lett· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective induction of anti-tumor immunity using p5 HER-2/neu derived peptide encapsulated in fusogenic DOTAP cationic liposomes co-administrated with CpG-ODN.
Mercedeh Mansourian, Ali Badiee, Seyed Amir Jalali, Sheida Shariat, Mona Yazdani

Immunol Lett· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis